Last updated: March 16, 2026
Sponsor: Nazmy Edward Seif
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Prostate Cancer, Early, Recurrent
Bladder Cancer
Surgery
Treatment
Mannitol Infusion
Fluid Regimen
Nitroglycerin Infusion
Clinical Study ID
NCT06408597
MVTKIPRARPC
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
ASA class I - III
Normal renal functions or Mild renal disease (GFR < 60 ml/min &/or presence ofalbuminuria > 30 mg/dl)
Exclusion
Exclusion Criteria:
BMI > 40
Previous renal surgery
Moderate (GFR 30 - 59 mg/dl) & severe (GFR 15 - 29 mg/dl) renal impairment
Decompensated cardiac disease: New York Heart Association (NYHA) class 3 or 4
Allergy to mannitol or nitroglycerin
Study Design
Total Participants: 90
Treatment Group(s): 3
Primary Treatment: Mannitol Infusion
Phase:
Study Start date:
May 12, 2024
Estimated Completion Date:
May 31, 2026
Connect with a study center
Cairo University Hospitals
Cairo,
EgyptSite Not Available
Cairo University Hospitals
Cairo 360630,
EgyptSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.